In the last trading session, 54.56 million Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares changed hands as the company’s beta touched 1.44. With the company’s per share price at $0.95 changed hands at $0.09 or 10.90% during last session, the market valuation stood at $1.99B. DNA’s last price was a discount, traded about -168.42% off its 52-week high of $2.55. The share price had its 52-week low at $0.74, which suggests the last value was 22.11% up since then. When we look at Ginkgo Bioworks Holdings Inc’s average trading volume, we note the 3-month average coming to 30.11 million.

Ginkgo Bioworks Holdings Inc (NYSE:DNA) trade information

Instantly DNA was in green as seen at the end of in last trading. With action 11.03%, the performance over the past five days has been green. The jump to weekly highs of 1.1300 added 10.90% to the stock’s daily price. The company’s shares are showing year-to-date downside of -43.49%, with the 5-day performance at 11.03% in the green. However, in the 30-day time frame, Ginkgo Bioworks Holdings Inc (NYSE:DNA) is -10.75% down.

Ginkgo Bioworks Holdings Inc (DNA) estimates and forecasts

Data shows that the Ginkgo Bioworks Holdings Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -29.78% over the past 6 months, a 17.95% in annual growth rate that is considerably higher than the industry average of 13.00%.

The 2024 estimates are for Ginkgo Bioworks Holdings Inc earnings to increase by 30.43%, but the outlook for the next 5-year period is at 19.50% per year.

DNA Dividends

Ginkgo Bioworks Holdings Inc is expected to release its next quarterly earnings report in June.